Finbold has selected three interesting pharmaceutical stocks that could see significant moves to the upside in 2025.

The pharmaceutical industry in 2024 faced a relatively quiet year, with deal volumes similar to 2023 but lower deal values, ...

Shares of Regeneron Pharmaceuticals, Inc. REGN have dropped 35.6% in the past six months compared with the industry’s decline ...

We recently compiled a list of the Best Medical Stocks To Buy Under $20. In this article, we are going to take a look at ...

Today, pharmaceutical stocks are tied to several treatment specialties ... While most people are familiar with the pharmaceutical industry’s impact on infectious diseases, advancements in ...

Shares of Piramal Pharma saw a sharp rally on January 13, 2025, rising over 8 per cent despite broader market weakness, with ...

According to the most recent exchange filing, Sudarshan Pharma Industries Ltd., a leading contract maker of speciality ...

Shares of Jagsonpal pharmaceutical stocks are going to ex- trade this morning as the stock split is scheduled today. The ...

The pharmaceutical industry can be a tough business. Companies must innovate constantly to stay relevant because patents ...

Citi initiated coverage of West Pharmaceutical (WST) with a Buy rating and $400 price target West is a provider of packaging and injectable ...

Crinetics Pharmaceuticals Inc (CRNX) stock saw a decline, ending the day at $40.59 which represents a decrease of $-7.91 or -16.31% from the prior close of $48.5. The stock opened at $46.64 and ...

In terms of valuation, Marinus Pharmaceuticals Inc’s market capitalization stands at $33.41 million. Market cap represents the total value of all outstanding shares and is a key indicator of a company ...